Glomerular expression of biglycan and decorin and urinary levels of decorin in primary glomerular disease

M. Kuroda, H. Sasamura, E. Kobayashi, Ryoko Shimizu, Y. Nakazato, M. Hayashi, T. Saruta

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Aims: Recent studies have suggested that small leucine-rich proteoglycans (SLRP) of the extracellular matrix play a major role in modulating the activity of growth factors and in regulating the deposition of collagens. In this study, the expression of the SLRPs biglycan and decorin in the glomeruli of patients with primary glomerular disease (minimal change disease, IgA nephropathy, and membranous nephropathy) and urine immunoreactive levels were examined. Methods: Renal biopsy specimens were obtained from patients with minimal change disease, IgA nephropathy and membranous nephropathy. Immunohistochemical staining was performed on fresh-frozen samples using anti-biglycan and anti-decorin antibodies. Examination of urine proteoglycan excretion from a total of 26 patients and 8 normal volunteers was performed by indirect ELISA. Results: In normal kidney samples, biglycan and decorin expression was found predominantly in the intrarenal arteries and tubulointerstitium, with only minimal expression in the glomeruli. Glomerular expression of these proteoglycans in glomerular disease was unchanged in all of the 4 patients examined with minimal change disease. In the case of IgA nephropathy or membranous nephropathy, some of the patients showed minimally increased immunostaining of either biglycan or decorin, but there were no signs of simultaneous upregulation of both proteoglycans. To further examine the changes in proteoglycan expression, ELISA was performed on urine samples. Urine biglycan levels were below detection levels, but high values of urine decorin immunoreactivity were found in the patients with glomerular disease. A significant negative correlation was found between urine decorin and creatinine clearance. Conclusion: These results suggest that distinct changes in the expression of the SLRPs biglycan and decorin may be seen in patients with primary glomerular disease. Moreover, the negative relationship between urine decorin levels and renal function supports the hypothesis that decorin may be involved in the pathophysiology of renal dysfunction in humans.

Original languageEnglish
Pages (from-to)7-16
Number of pages10
JournalClinical Nephrology
Volume61
Issue number1
Publication statusPublished - 2004 Jan

Fingerprint

Biglycan
Decorin
Urine
Proteoglycans
Lipoid Nephrosis
Membranous Glomerulonephritis
Immunoglobulin A
Kidney
Enzyme-Linked Immunosorbent Assay
Extracellular Matrix
Anti-Idiotypic Antibodies
Creatinine
Intercellular Signaling Peptides and Proteins
Healthy Volunteers
Up-Regulation
Collagen
Arteries
Staining and Labeling

Keywords

  • Biglycan
  • Decorin
  • ELISA
  • Glomerulonephritis
  • Proteoglycan

ASJC Scopus subject areas

  • Nephrology

Cite this

Kuroda, M., Sasamura, H., Kobayashi, E., Shimizu, R., Nakazato, Y., Hayashi, M., & Saruta, T. (2004). Glomerular expression of biglycan and decorin and urinary levels of decorin in primary glomerular disease. Clinical Nephrology, 61(1), 7-16.

Glomerular expression of biglycan and decorin and urinary levels of decorin in primary glomerular disease. / Kuroda, M.; Sasamura, H.; Kobayashi, E.; Shimizu, Ryoko; Nakazato, Y.; Hayashi, M.; Saruta, T.

In: Clinical Nephrology, Vol. 61, No. 1, 01.2004, p. 7-16.

Research output: Contribution to journalArticle

Kuroda, M, Sasamura, H, Kobayashi, E, Shimizu, R, Nakazato, Y, Hayashi, M & Saruta, T 2004, 'Glomerular expression of biglycan and decorin and urinary levels of decorin in primary glomerular disease', Clinical Nephrology, vol. 61, no. 1, pp. 7-16.
Kuroda, M. ; Sasamura, H. ; Kobayashi, E. ; Shimizu, Ryoko ; Nakazato, Y. ; Hayashi, M. ; Saruta, T. / Glomerular expression of biglycan and decorin and urinary levels of decorin in primary glomerular disease. In: Clinical Nephrology. 2004 ; Vol. 61, No. 1. pp. 7-16.
@article{74f78ee8fb8b4a159caa913d2ce58c82,
title = "Glomerular expression of biglycan and decorin and urinary levels of decorin in primary glomerular disease",
abstract = "Aims: Recent studies have suggested that small leucine-rich proteoglycans (SLRP) of the extracellular matrix play a major role in modulating the activity of growth factors and in regulating the deposition of collagens. In this study, the expression of the SLRPs biglycan and decorin in the glomeruli of patients with primary glomerular disease (minimal change disease, IgA nephropathy, and membranous nephropathy) and urine immunoreactive levels were examined. Methods: Renal biopsy specimens were obtained from patients with minimal change disease, IgA nephropathy and membranous nephropathy. Immunohistochemical staining was performed on fresh-frozen samples using anti-biglycan and anti-decorin antibodies. Examination of urine proteoglycan excretion from a total of 26 patients and 8 normal volunteers was performed by indirect ELISA. Results: In normal kidney samples, biglycan and decorin expression was found predominantly in the intrarenal arteries and tubulointerstitium, with only minimal expression in the glomeruli. Glomerular expression of these proteoglycans in glomerular disease was unchanged in all of the 4 patients examined with minimal change disease. In the case of IgA nephropathy or membranous nephropathy, some of the patients showed minimally increased immunostaining of either biglycan or decorin, but there were no signs of simultaneous upregulation of both proteoglycans. To further examine the changes in proteoglycan expression, ELISA was performed on urine samples. Urine biglycan levels were below detection levels, but high values of urine decorin immunoreactivity were found in the patients with glomerular disease. A significant negative correlation was found between urine decorin and creatinine clearance. Conclusion: These results suggest that distinct changes in the expression of the SLRPs biglycan and decorin may be seen in patients with primary glomerular disease. Moreover, the negative relationship between urine decorin levels and renal function supports the hypothesis that decorin may be involved in the pathophysiology of renal dysfunction in humans.",
keywords = "Biglycan, Decorin, ELISA, Glomerulonephritis, Proteoglycan",
author = "M. Kuroda and H. Sasamura and E. Kobayashi and Ryoko Shimizu and Y. Nakazato and M. Hayashi and T. Saruta",
year = "2004",
month = "1",
language = "English",
volume = "61",
pages = "7--16",
journal = "Clinical Nephrology",
issn = "0301-0430",
publisher = "Dustri-Verlag Dr. Karl Feistle",
number = "1",

}

TY - JOUR

T1 - Glomerular expression of biglycan and decorin and urinary levels of decorin in primary glomerular disease

AU - Kuroda, M.

AU - Sasamura, H.

AU - Kobayashi, E.

AU - Shimizu, Ryoko

AU - Nakazato, Y.

AU - Hayashi, M.

AU - Saruta, T.

PY - 2004/1

Y1 - 2004/1

N2 - Aims: Recent studies have suggested that small leucine-rich proteoglycans (SLRP) of the extracellular matrix play a major role in modulating the activity of growth factors and in regulating the deposition of collagens. In this study, the expression of the SLRPs biglycan and decorin in the glomeruli of patients with primary glomerular disease (minimal change disease, IgA nephropathy, and membranous nephropathy) and urine immunoreactive levels were examined. Methods: Renal biopsy specimens were obtained from patients with minimal change disease, IgA nephropathy and membranous nephropathy. Immunohistochemical staining was performed on fresh-frozen samples using anti-biglycan and anti-decorin antibodies. Examination of urine proteoglycan excretion from a total of 26 patients and 8 normal volunteers was performed by indirect ELISA. Results: In normal kidney samples, biglycan and decorin expression was found predominantly in the intrarenal arteries and tubulointerstitium, with only minimal expression in the glomeruli. Glomerular expression of these proteoglycans in glomerular disease was unchanged in all of the 4 patients examined with minimal change disease. In the case of IgA nephropathy or membranous nephropathy, some of the patients showed minimally increased immunostaining of either biglycan or decorin, but there were no signs of simultaneous upregulation of both proteoglycans. To further examine the changes in proteoglycan expression, ELISA was performed on urine samples. Urine biglycan levels were below detection levels, but high values of urine decorin immunoreactivity were found in the patients with glomerular disease. A significant negative correlation was found between urine decorin and creatinine clearance. Conclusion: These results suggest that distinct changes in the expression of the SLRPs biglycan and decorin may be seen in patients with primary glomerular disease. Moreover, the negative relationship between urine decorin levels and renal function supports the hypothesis that decorin may be involved in the pathophysiology of renal dysfunction in humans.

AB - Aims: Recent studies have suggested that small leucine-rich proteoglycans (SLRP) of the extracellular matrix play a major role in modulating the activity of growth factors and in regulating the deposition of collagens. In this study, the expression of the SLRPs biglycan and decorin in the glomeruli of patients with primary glomerular disease (minimal change disease, IgA nephropathy, and membranous nephropathy) and urine immunoreactive levels were examined. Methods: Renal biopsy specimens were obtained from patients with minimal change disease, IgA nephropathy and membranous nephropathy. Immunohistochemical staining was performed on fresh-frozen samples using anti-biglycan and anti-decorin antibodies. Examination of urine proteoglycan excretion from a total of 26 patients and 8 normal volunteers was performed by indirect ELISA. Results: In normal kidney samples, biglycan and decorin expression was found predominantly in the intrarenal arteries and tubulointerstitium, with only minimal expression in the glomeruli. Glomerular expression of these proteoglycans in glomerular disease was unchanged in all of the 4 patients examined with minimal change disease. In the case of IgA nephropathy or membranous nephropathy, some of the patients showed minimally increased immunostaining of either biglycan or decorin, but there were no signs of simultaneous upregulation of both proteoglycans. To further examine the changes in proteoglycan expression, ELISA was performed on urine samples. Urine biglycan levels were below detection levels, but high values of urine decorin immunoreactivity were found in the patients with glomerular disease. A significant negative correlation was found between urine decorin and creatinine clearance. Conclusion: These results suggest that distinct changes in the expression of the SLRPs biglycan and decorin may be seen in patients with primary glomerular disease. Moreover, the negative relationship between urine decorin levels and renal function supports the hypothesis that decorin may be involved in the pathophysiology of renal dysfunction in humans.

KW - Biglycan

KW - Decorin

KW - ELISA

KW - Glomerulonephritis

KW - Proteoglycan

UR - http://www.scopus.com/inward/record.url?scp=0346505363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346505363&partnerID=8YFLogxK

M3 - Article

C2 - 14964452

AN - SCOPUS:0346505363

VL - 61

SP - 7

EP - 16

JO - Clinical Nephrology

JF - Clinical Nephrology

SN - 0301-0430

IS - 1

ER -